• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾素-钠分析及转化酶抑制所提示的肾素在高血压中的可能作用。

Possible role of renin in hypertension as suggested by renin-sodium profiling and inhibition of converting enzyme.

作者信息

Case D B, Wallace J M, Keim H J, Weber M A, Sealey J E, Laragh J H

出版信息

N Engl J Med. 1977 Mar 24;296(12):641-6. doi: 10.1056/NEJM197703242961201.

DOI:10.1056/NEJM197703242961201
PMID:190537
Abstract

To block renin activity, a nonapeptide converting-enzyme inhibitor was given to 65 seated hypertensive patients. Depressor responses occurred only when control plasma renin activity exceeded 2 ng of angiotensin I per milliliter per hour and correlated directly in amplitude with control plasma renin activity and with induced increments in activity (P less than 0.001 for both). Depressor responses, like renin activity, were characteristic for renin subgroups as defined by renin-sodium profiling. Before and after sodium deprivation, the nonapeptide reduced diastolic pressure in all patients with high renin (by 17.3 and 19.8 per cent) and most patients with normal renin (by 9.1 and 17.7 per cent). Low-renin patients remained unresponsive. This enzyme blockade may cause bradykinin accumulation. But if, as seems likely, depressor responses are due to blockade of angiotensin II formation, the results indicate that, irrespective of sodium balance, measurements of plasma renin activity reflect its contribution to blood-pressure maintenance. The results suggest broad participation of the renin system in common forms of hypertension.

摘要

为阻断肾素活性,对65名坐位高血压患者给予一种九肽转化酶抑制剂。仅当对照血浆肾素活性超过每小时每毫升2纳克血管紧张素I时才出现降压反应,且降压反应的幅度与对照血浆肾素活性以及诱导的活性增量直接相关(两者的P均小于0.001)。如肾素 - 钠谱分析所定义,降压反应与肾素亚组的肾素活性一样具有特征性。在限钠前后,该九肽使所有高肾素患者的舒张压降低(分别降低17.3%和19.8%),使大多数正常肾素患者的舒张压降低(分别降低9.1%和17.7%)。低肾素患者无反应。这种酶阻断可能导致缓激肽蓄积。但如果降压反应很可能是由于血管紧张素II生成受阻所致,那么结果表明,无论钠平衡如何,血浆肾素活性的测定反映了其对血压维持的作用。结果提示肾素系统广泛参与常见类型的高血压。

相似文献

1
Possible role of renin in hypertension as suggested by renin-sodium profiling and inhibition of converting enzyme.肾素-钠分析及转化酶抑制所提示的肾素在高血压中的可能作用。
N Engl J Med. 1977 Mar 24;296(12):641-6. doi: 10.1056/NEJM197703242961201.
2
Accentuated vascular and endocrine response to SQ 20881 in hypertension.高血压患者对SQ 20881的血管和内分泌反应增强。
N Engl J Med. 1977 Jul 28;297(4):184-8. doi: 10.1056/NEJM197707282970404.
3
Estimating renin participation in hypertension: superiority of converting enzyme inhibitor over saralasin.评估肾素在高血压中的作用:转换酶抑制剂相对于沙拉新的优势。
Am J Med. 1976 Nov;61(5):790-6. doi: 10.1016/0002-9343(76)90160-1.
4
Blockade of renin or angiotensin for understanding human hypertension: a comparison of propranolol, saralasin and converting enzyme blockade.通过阻断肾素或血管紧张素理解人类高血压:普萘洛尔、沙拉新与转换酶阻断作用的比较
Fed Proc. 1977 Apr;36(5):1781-7.
5
Renin--angiotensin antagonists and the regulation of blood pressure.肾素 - 血管紧张素拮抗剂与血压调节
Fed Proc. 1976 Nov;35(13):2512-20.
6
Comparison between saralsin and converting enzyme inhibitor in hypertensive disease.高血压病中沙拉新与转换酶抑制剂的比较。
Kidney Int Suppl. 1979 Mar(9):S107-114.
7
The renin-angiotensin-aldosterone system in congestive failure in conscious dogs.清醒犬充血性心力衰竭时的肾素-血管紧张素-醛固酮系统
J Clin Invest. 1976 Jun;57(6):1606-17. doi: 10.1172/JCI108431.
8
The inhibition of rat renin in sodium depleted and renal hypertensive rats. Comparison of purified antibodies or Fab fragments against mouse submaxillary renin with SQ 20881, and the effect on blood pressure homeostasis.钠缺乏和肾性高血压大鼠中大鼠肾素的抑制作用。抗小鼠颌下腺肾素的纯化抗体或Fab片段与SQ 20881的比较及其对血压稳态的影响。
Scand J Urol Nephrol Suppl. 1984;79:17-22.
9
Tubuloglomerular feedback and single nephron function after converting enzyme inhibition in the rat.大鼠转换酶抑制后肾小管-肾小球反馈及单肾单位功能
J Clin Invest. 1979 Nov;64(5):1325-35. doi: 10.1172/JCI109589.
10
Relationship between aldosterone and bradykinin.醛固酮与缓激肽之间的关系。
Circ Res. 1977 May;40(5 Suppl 1):I84-8.

引用本文的文献

1
Optimizing Precision of Hypertension Care to Maximize Blood Pressure Control: A Pilot Study Utilizing a Smartphone App to Incorporate Plasma Renin Activity Testing.优化高血压治疗精准度以最大程度控制血压:利用智能手机应用程序纳入血浆肾素活性检测的一项试点研究。
Clin Transl Sci. 2021 Mar;14(2):617-624. doi: 10.1111/cts.12922. Epub 2020 Nov 30.
2
Augmenting Renal Lymphatic Density Prevents Angiotensin II-Induced Hypertension in Male and Female Mice.增强肾脏淋巴管密度可预防雄性和雌性小鼠血管紧张素 II 诱导的高血压。
Am J Hypertens. 2020 Jan 1;33(1):61-69. doi: 10.1093/ajh/hpz139.
3
Sex Differences in Hypertension: Where We Have Been and Where We Are Going.
高血压中的性别差异:我们的过去与未来。
Am J Hypertens. 2018 Nov 13;31(12):1247-1254. doi: 10.1093/ajh/hpy148.
4
John H. Laragh, MD: clinician-scientist.约翰·H·拉腊格医学博士:临床科学家。
Am J Hypertens. 2014 Aug;27(8):1019-23. doi: 10.1093/ajh/hpu110.
5
Plasma renin activity predicts blood pressure responses to beta-blocker and thiazide diuretic as monotherapy and add-on therapy for hypertension.血浆肾素活性可预测β受体阻滞剂和噻嗪类利尿剂单药治疗及高血压联合治疗时的血压反应。
Am J Hypertens. 2010 Sep;23(9):1014-22. doi: 10.1038/ajh.2010.98. Epub 2010 Aug 19.
6
Hypertension management: differing points of view. Should we routinely measure renin levels to diagnose and treat patients with hypertension? The argument for.高血压管理:不同观点。我们是否应该常规测量肾素水平以诊断和治疗高血压患者?支持的观点。
J Clin Hypertens (Greenwich). 2005 Jan;7(1):33-5; quiz 38-9. doi: 10.1111/j.1524-6175.2005.03942.x.
7
Plasma renin measurement in the management of hypertension: the V and R hypothesis.血浆肾素测定在高血压管理中的应用:V与R假说
J Clin Hypertens (Greenwich). 2003 Nov-Dec;5(6):373-6. doi: 10.1111/j.1524-6175.2003.02870.x.
8
Optimal dosage of ACE inhibitors in older patients.老年患者中血管紧张素转换酶抑制剂的最佳剂量
Drugs Aging. 1996 Oct;9(4):262-73. doi: 10.2165/00002512-199609040-00004.
9
Recent pathogenic aspects in essential hypertension and hypertension associated with diabetes mellitus.原发性高血压及糖尿病相关性高血压的近期发病机制
Klin Wochenschr. 1980 Oct 1;58(19):1071-89. doi: 10.1007/BF01476878.
10
Control of essential hypertension with captopril, an angiotensin converting enzyme inhibitor.使用血管紧张素转换酶抑制剂卡托普利控制原发性高血压。
Br J Clin Pharmacol. 1981 May;11(5):469-75. doi: 10.1111/j.1365-2125.1981.tb01152.x.